ANA 2020: Investigational Combination of Rizatriptan and Reformulated Meloxicam Shows Promise in Migraine
The compound was superior to either agent alone in multiple efficacy measures
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.